Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 16, 2020 08:00 ET | Source: Receptor Holding

Receptor Life Sciences Receives Schedule I Research License from U.S. Drug Enforcement Agency

SEATTLE, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Receptor Life Sciences announced today that the Company was granted a Schedule I research license from the United States Drug Enforcement Agency (DEA). ...
November 11, 2020 08:00 ET | Source: Receptor Holding

Receptor Life Sciences Names Gregory Mayes to Board of Directors

SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Receptor Life Sciences (Receptor) today announced the appointment of Gregory T. Mayes, J.D. to its Board of Directors. Mr. Mayes is an expert in...
September 14, 2020 08:00 ET | Source: Receptor Holding

New Clinical Pharmacokinetic Study Demonstrates Proof-of-Concept for Receptor Life Science’s Investigational Cannabinoid-based Product Candidates

NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Data from an initial proof-of-concept clinical pharmacokinetic study demonstrate that Receptor Life Sciences' research team has found a way to address...
March 19, 2020 12:40 ET | Source: Receptor Holding

Receptor Life Sciences Secures U.S. Patent for its Oral Absorption Enhancing Excipients with Cannabinoids

SEATTLE, March 19, 2020 (GLOBE NEWSWIRE) -- Receptor Life Sciences (“RLS”), a leading biopharmaceutical company developing FDA regulated oral and inhaled cannabinoid medicines, today announced that...
October 07, 2019 08:00 ET | Source: Receptor Holding

Receptor Holdings Expands Board of Directors with Pharmaceutical Industry Business Development Leader James Weissman

SEATTLE, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Receptor Holdings (RHI) and its subsidiary, Receptor Life Sciences, Inc. (RLS), a leading biopharmaceutical company developing FDA-regulated oral and...
June 24, 2019 08:00 ET | Source: Receptor Holding

Nationally Recognized Medical Experts Join Receptor Life Science’s Scientific Advisory Board to Guide the Development of New Cannabinoid Therapies

SEATTLE, June 24, 2019 (GLOBE NEWSWIRE) -- Receptor Life Sciences (RLS), a leader in FDA-regulated cannabinoid medicine drug development using proprietary delivery technologies, today announced the...
April 08, 2019 08:50 ET | Source: Receptor Holding

Receptor Holdings Adds Alex Casdin to Board of Directors

SEATTLE, April 08, 2019 (GLOBE NEWSWIRE) -- Alexander W. Casdin, Founder, CEO, and Portfolio Manager of Reneo Capital Management LP, has been named to the Board of Directors of Receptor Holdings...